AFP and neoplasm: Cohen et al. evaluated a number of tumor markers for cancer screening in a case-control study, and found that some markers (including AFP, CEA, CA19-9, CYFRA21-1, CA125, and CA15-3) could be used together as a panel, to improve performance [10].